Short-bowel syndrome
- PMID: 8792142
Short-bowel syndrome
Abstract
Short-bowel syndrome refers to the clinical sequelae of resection of a substantial portion of the small intestine. Features of diarrhea, dehydration, malabsorption, malnutrition, or weight loss generally occur, at least transiently, when more than 75% of the small intestine is resected, although other factors in addition to residual length affect clinical outcome. Adaptation of the remnant bowel has been well documented to occur over months to years following resection, although the agents responsible for this process are not well defined. Ambulatory total parenteral nutrition has greatly improved the prognosis of this syndrome over the last 25 years. We review the anatomical and the pathophysiological basis of this syndrome, discuss its clinical manifestations, and review current knowledge of intestinal adaptation. We also review medical and surgical therapeutic options for these patients, as well as dietary, enteral, and parenteral nutritional aspects of their care.
Similar articles
-
Survival rate and prognostic factors in patients with intestinal failure.Dig Liver Dis. 2004 Jan;36(1):46-55. doi: 10.1016/j.dld.2003.09.015. Dig Liver Dis. 2004. PMID: 14971815
-
Short bowel syndrome.Semin Pediatr Surg. 1995 Feb;4(1):60-72; discussion 72-3. Semin Pediatr Surg. 1995. PMID: 7728510 Review.
-
Factors affecting postoperative dietary adaptation in short bowel syndrome.Hepatogastroenterology. 2009 Jul-Aug;56(93):1049-52. Hepatogastroenterology. 2009. PMID: 19760939
-
Nutritional management of short bowel syndrome.Semin Gastrointest Dis. 2002 Jul;13(3):161-8. Semin Gastrointest Dis. 2002. PMID: 12230319 Review.
-
Management of the short bowel syndrome after extensive small bowel resection.Best Pract Res Clin Gastroenterol. 2004 Oct;18(5):977-92. doi: 10.1016/j.bpg.2004.05.002. Best Pract Res Clin Gastroenterol. 2004. PMID: 15494290 Review.
Cited by
-
Adult zebrafish intestine resection: a novel model of short bowel syndrome, adaptation, and intestinal stem cell regeneration.Am J Physiol Gastrointest Liver Physiol. 2015 Aug 1;309(3):G135-45. doi: 10.1152/ajpgi.00311.2014. Epub 2015 Jun 18. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 26089336 Free PMC article.
-
Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function.Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G664-77. doi: 10.1152/ajpgi.00111.2014. Epub 2015 Jan 8. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25573173 Free PMC article.
-
R-Spondin 1 (RSPO1) Increases Mouse Intestinal Organoid Unit Size and Survival in vitro and Improves Tissue-Engineered Small Intestine Formation in vivo.Front Bioeng Biotechnol. 2020 Jun 5;8:476. doi: 10.3389/fbioe.2020.00476. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32582652 Free PMC article.
-
A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.Tissue Eng Part A. 2011 Jul;17(13-14):1841-50. doi: 10.1089/ten.TEA.2010.0564. Epub 2011 May 4. Tissue Eng Part A. 2011. PMID: 21395443 Free PMC article.
-
Tissue-engineered small intestine improves recovery after massive small bowel resection.Ann Surg. 2004 Nov;240(5):748-54. doi: 10.1097/01.sla.0000143246.07277.73. Ann Surg. 2004. PMID: 15492554 Free PMC article.